$AAPI
Apple iSports Group, Inc.

2023 Q4 Form 10-K Financial Statement

#000147793224002287 Filed on April 22, 2024

View on sec.gov

Income Statement

Concept 2023 Q4 2023 2022
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $56.00K
YoY Change 34.74%
% of Gross Profit
Research & Development $664.0K $0.00
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $3.603M $56.00K
YoY Change 6334.13% 34.74%
Operating Profit -$3.603M -$56.00K
YoY Change 6334.7% 34.73%
Interest Expense $60.75K $15.81K
YoY Change 284.18%
% of Operating Profit
Other Income/Expense, Net $75.21K $22.28K
YoY Change 237.64%
Pretax Income -$3.678M -$56.00K
YoY Change 6468.43% 34.74%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$3.678M -$56.00K
YoY Change 6469.02% 34.73%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$7.328K
COMMON SHARES
Basic Shares Outstanding 202.8M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q4 2023 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.160K
YoY Change 1417.65%
Cash & Equivalents $673.00
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $69.38K $5.160K
YoY Change 1309.08% 1417.65%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $100.00
YoY Change 0.0%
Other Assets
YoY Change
Total Long-Term Assets $0.00 $100.00
YoY Change -100.0% 0.0%
TOTAL ASSETS
Total Short-Term Assets $69.38K $5.160K
Total Long-Term Assets $0.00 $100.00
Total Assets $69.38K $5.260K
YoY Change 1281.03% 1095.45%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $30.91K
YoY Change 7.89%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $5.377M $153.2K
YoY Change 2900.29% 65.82%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $5.377M $153.2K
Total Long-Term Liabilities $0.00
Total Liabilities $5.377M $153.2K
YoY Change 2900.29% 65.82%
SHAREHOLDERS EQUITY
Retained Earnings -$10.44M
YoY Change 101.78%
Common Stock $20.28K
YoY Change 2554.19%
Preferred Stock
YoY Change
Treasury Stock (at cost) $52.95K
YoY Change 0.0%
Treasury Stock Shares
Shareholders Equity -$5.307M -$148.0K
YoY Change
Total Liabilities & Shareholders Equity $69.38K $5.260K
YoY Change 1281.03% 1095.45%

Cashflow Statement

Concept 2023 Q4 2023 2022
OPERATING ACTIVITIES
Net Income -$3.678M -$56.00K
YoY Change 6469.02% 34.73%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$1.467M -$53.73K
YoY Change 2629.38% 8.31%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $100.0K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $1.469M $58.55K
YoY Change 2408.83% 17.22%
NET CHANGE
Cash From Operating Activities -$1.467M -$53.73K
Cash From Investing Activities
Cash From Financing Activities $1.469M $58.55K
Net Change In Cash -$19.18K $4.819K
YoY Change -498.09% 1317.35%
FREE CASH FLOW
Cash From Operating Activities -$1.467M -$53.73K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7642211 shares
CY2023Q4 us-gaap Foreign Currency Exchange Rate Translation1
ForeignCurrencyExchangeRateTranslation1
0.6640 pure
CY2022Q4 us-gaap Foreign Currency Exchange Rate Translation1
ForeignCurrencyExchangeRateTranslation1
0.6947 pure
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
195062000 shares
CY2023Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
80000 shares
CY2023Q2 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
1.25
CY2023Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
100000 usd
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001134982
CY2023Q4 aapi Due To Related Party Current
DueToRelatedPartyCurrent
4999 usd
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7642211 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
202784211 shares
CY2023Q4 aapi Treasury Stock Shares1
TreasuryStockShares1
1 shares
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
000-32389
CY2023 dei Entity Registrant Name
EntityRegistrantName
APPLE iSPORTS GROUP, INC.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
88-0126444
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
552 Lonsdale Street
CY2023 dei Entity Address Address Line2
EntityAddressAddressLine2
Level 7
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Melbourne
CY2023 dei Entity Address Country
EntityAddressCountry
AU
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
3000
CY2023 dei City Area Code
CityAreaCode
61
CY2023 dei Local Phone Number
LocalPhoneNumber
3 8393 1459
CY2023 dei Security12g Title
Security12gTitle
Common Stock, $0.0001 par value per share
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023 dei Entity Ex Transition Period
EntityExTransitionPeriod
true
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
71993262 usd
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
202784211 shares
CY2023 dei Auditor Firm
AuditorFirmId
536
CY2023 dei Auditor Name
AuditorName
Morison Cogen LLP
CY2023 dei Auditor Location
AuditorLocation
Blue Bell, Pennsylvania
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
673 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
19857 usd
CY2023Q4 aapi Goods And Service Tax Receivable
GoodsAndServiceTaxReceivable
61798 usd
CY2022Q4 aapi Goods And Service Tax Receivable
GoodsAndServiceTaxReceivable
14120 usd
CY2023Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
100 usd
CY2022Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
100 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
6812 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
6766 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
69383 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
40843 usd
CY2023Q4 us-gaap Assets
Assets
69383 usd
CY2022Q4 us-gaap Assets
Assets
40843 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2464558 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
319537 usd
CY2022Q4 aapi Due To Related Party Current
DueToRelatedPartyCurrent
4699 usd
CY2023Q4 us-gaap Loans Payable
LoansPayable
2720549 usd
CY2022Q4 us-gaap Loans Payable
LoansPayable
1310873 usd
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
77964 usd
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
16248 usd
CY2023Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
108487 usd
CY2022Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
31249 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5376557 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1682606 usd
CY2023Q4 us-gaap Liabilities
Liabilities
5376557 usd
CY2022Q4 us-gaap Liabilities
Liabilities
1682606 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
20278 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
764 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
5223245 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
5142759 usd
CY2022Q4 aapi Treasury Stock Shares1
TreasuryStockShares1
1 shares
CY2023Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
52954 usd
CY2022Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
52954 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-60130 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
26958 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-10437613 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6759290 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-5307174 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1641763 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
69383 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
40843 usd
CY2023 us-gaap Revenues
Revenues
0 usd
CY2022 us-gaap Revenues
Revenues
0 usd
CY2023 us-gaap Salaries And Wages
SalariesAndWages
548582 usd
CY2022 us-gaap Salaries And Wages
SalariesAndWages
480664 usd
CY2023 us-gaap Professional Fees
ProfessionalFees
1580451 usd
CY2022 us-gaap Professional Fees
ProfessionalFees
628316 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
810066 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
438821 usd
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
664011 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
0 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
3603110 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
1547801 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-3603110 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-1547801 usd
CY2023 us-gaap Interest Expense
InterestExpense
60746 usd
CY2022 us-gaap Interest Expense
InterestExpense
15812 usd
CY2023 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
14467 usd
CY2022 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
6464 usd
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
75213 usd
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
22276 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-3678323 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1570077 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-3678323 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-1570077 usd
CY2023 us-gaap Temporary Equity Foreign Currency Translation Adjustments
TemporaryEquityForeignCurrencyTranslationAdjustments
-87088 usd
CY2022 us-gaap Temporary Equity Foreign Currency Translation Adjustments
TemporaryEquityForeignCurrencyTranslationAdjustments
24967 usd
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3765411 usd
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1545110 usd
CY2023 aapi Net Loss Per Share Basic And Diluted
NetLossPerShareBasicAndDiluted
-0.02
CY2022 aapi Net Loss Per Share Basic And Diluted
NetLossPerShareBasicAndDiluted
-0.20
CY2023 aapi Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
202746293 shares
CY2022 aapi Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
7642211 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-158654 usd
CY2022 aapi Stock Issued During Period Value New Issues Subsidiary
StockIssuedDuringPeriodValueNewIssuesSubsidiary
62000 usd
CY2022 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
24967 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-1570077 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1641763 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1641763 usd
CY2023 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
100000 usd
CY2023 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-87088 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-3678323 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-5307174 usd
CY2023 us-gaap Profit Loss
ProfitLoss
3678323 usd
CY2022 us-gaap Profit Loss
ProfitLoss
1570077 usd
CY2023 aapi Foreign Currency Transaction Gain Loss
ForeignCurrencyTransactionGainLoss
14467 usd
CY2022 aapi Foreign Currency Transaction Gain Loss
ForeignCurrencyTransactionGainLoss
0 usd
CY2023 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
46384 usd
CY2022 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
11326 usd
CY2023 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2108523 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
262046 usd
CY2023 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
60111 usd
CY2022 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
16218 usd
CY2023 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
75085 usd
CY2022 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
31249 usd
CY2023 us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
0 usd
CY2022 us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
6766 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1466521 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1278656 usd
CY2023 aapi Payments Advances To Related Party
PaymentsAdvancesToRelatedParty
300 usd
CY2022 aapi Payments Advances To Related Party
PaymentsAdvancesToRelatedParty
1991 usd
CY2023 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
1368621 usd
CY2022 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
1195890 usd
CY2023 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
100000 usd
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
62000 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1468921 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1259881 usd
CY2023 aapi Effect Of Exchange Rates On Cash And Cash Equivalents
EffectOfExchangeRatesOnCashAndCashEquivalents
-21584 usd
CY2022 aapi Effect Of Exchange Rates On Cash And Cash Equivalents
EffectOfExchangeRatesOnCashAndCashEquivalents
24967 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-19184 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
6193 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
19857 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13664 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
673 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
19857 usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2023 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2022 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2023Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
195062000 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-3678323 usd
CY2023Q4 aapi Working Capital
WorkingCapital
-5307174 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-10437613 usd
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
664011 usd
CY2023Q4 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
664011 usd
CY2023Q4 aapi Exchange Rate Period End
ExchangeRatePeriodEnd
0.6812 pure
CY2022Q4 aapi Exchange Rate Period End
ExchangeRatePeriodEnd
0.6766 pure
CY2023Q4 us-gaap Loans Payable Current
LoansPayableCurrent
2720549 usd
CY2022Q4 us-gaap Loans Payable Current
LoansPayableCurrent
1310873 usd
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
77964 usd
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
16248 usd
CY2023Q4 aapi Due To Officers Or Stockholder Current
DueToOfficersOrStockholderCurrent
4999 usd
CY2022Q4 aapi Due To Officers Or Stockholder Current
DueToOfficersOrStockholderCurrent
4699 usd
CY2023Q4 aapi Due To Related Party Current
DueToRelatedPartyCurrent
4999 usd
CY2022Q4 aapi Due To Related Party Current
DueToRelatedPartyCurrent
4699 usd
CY2023Q4 aapi Due To Officers Or Stockholder Current
DueToOfficersOrStockholderCurrent
4999 usd
CY2022Q4 aapi Due To Officers Or Stockholder Current
DueToOfficersOrStockholderCurrent
4699 usd
CY2023Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
2495974 usd
CY2022Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
1526516 usd
CY2023 us-gaap Current Federal State And Local Tax Expense Benefit
CurrentFederalStateAndLocalTaxExpenseBenefit
0 usd
CY2022 us-gaap Current Federal State And Local Tax Expense Benefit
CurrentFederalStateAndLocalTaxExpenseBenefit
0 usd
CY2023 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
969458 usd
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
338616 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.25 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.25 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.069 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.069 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.198 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.198 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.517 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.517 pure
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000 pure
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000 pure
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1673403 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
703945 usd
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2023Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q1 aapi Common Stock Shares Purchase Of Warrants
CommonStockSharesPurchaseOfWarrants
31000 shares
CY2023Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
52954 usd

Files In Submission

Name View Source Status
0001477932-24-002287-index-headers.html Edgar Link pending
0001477932-24-002287-index.html Edgar Link pending
0001477932-24-002287.txt Edgar Link pending
0001477932-24-002287-xbrl.zip Edgar Link pending
aapi-20231231.xsd Edgar Link pending
aapi_10k.htm Edgar Link pending
aapi_10kimg19.jpg Edgar Link pending
aapi_10kimg20.jpg Edgar Link pending
aapi_10kimg21.jpg Edgar Link pending
aapi_10kimg22.jpg Edgar Link pending
aapi_10kimg23.jpg Edgar Link pending
aapi_10kimg24.jpg Edgar Link pending
aapi_10kimg25.jpg Edgar Link pending
aapi_10kimg26.jpg Edgar Link pending
aapi_10kimg27.jpg Edgar Link pending
aapi_ex311.htm Edgar Link pending
aapi_ex321.htm Edgar Link pending
appi_ex21.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
aapi-20231231_cal.xml Edgar Link unprocessable
aapi-20231231_def.xml Edgar Link unprocessable
aapi-20231231_lab.xml Edgar Link unprocessable
aapi-20231231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
aapi_10k_htm.xml Edgar Link completed
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending